Market Resilience: Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Finishes Weak at 21.24, Down -0.28

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) closed the day trading at $21.24 down -0.28% from the previous closing price of $21.30. In other words, the price has decreased by -$0.28 from its previous closing price. On the day, 5.19 million shares were traded. TEVA stock price reached its highest trading level at $21.58 during the session, while it also had its lowest trading level at $21.095.

Ratios:

For a better understanding of TEVA, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.26 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.80. For the most recent quarter (mrq), Quick Ratio is recorded 0.61 and its Current Ratio is at 0.89. In the meantime, Its Debt-to-Equity ratio is 3.18 whereas as Long-Term Debt/Eq ratio is at 2.75.

On March 08, 2024, JP Morgan Upgraded its rating to Neutral which previously was Underweight but kept the price unchanged to $14.

Piper Sandler Upgraded its Neutral to Overweight on February 12, 2024, whereas the target price for the stock was revised from $12 to $19.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 20 ’24 when MIGNONE ROBERTO sold 286,000 shares for $22.01 per share. The transaction valued at 6,294,031 led to the insider holds 695,000 shares of the business.

Bridger Management, LLC (1) bought 286,000 shares of TEVA for $6,094,660 on Dec 20 ’24. On Nov 20 ’24, another insider, Fox Christine, who serves as the EVP, Head of U.S. Commercial of the company, sold 19,388 shares for $16.87 each. As a result, the insider received 327,085 and left with 44,104 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TEVA now has a Market Capitalization of 24892217344 and an Enterprise Value of 40340987904. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.43 while its Price-to-Book (P/B) ratio in mrq is 3.97. Its current Enterprise Value per Revenue stands at 2.405 whereas that against EBITDA is 8.429.

Stock Price History:

Over the past 52 weeks, TEVA has reached a high of $22.80, while it has fallen to a 52-week low of $10.75. The 50-Day Moving Average of the stock is 14.96%, while the 200-Day Moving Average is calculated to be 25.12%.

Shares Statistics:

Over the past 3-months, TEVA traded about 8.26M shares per day on average, while over the past 10 days, TEVA traded about 8616210 shares per day. A total of 1.13B shares are outstanding, with a floating share count of 1.13B. Insiders hold about 0.01% of the company’s shares, while institutions hold 56.89% stake in the company. Shares short for TEVA as of 1734048000 were 23220122 with a Short Ratio of 2.81, compared to 1731628800 on 21191235. Therefore, it implies a Short% of Shares Outstanding of 23220122 and a Short% of Float of 2.0599999.

Dividends & Splits

The stock’s 5-year Average Dividend Yield is 2.95.

Most Popular